共 50 条
Point mutation tRNASer(UCN) in a child with hearing loss and myoclonus epilepsy
被引:4
|作者:
Ramelli, GP
[1
]
Gallati, S
Weis, J
Krähenbühl, S
Burgunder, JM
机构:
[1] Osped San Giovanni Bellinzona, Dept Pediat, CH-6500 Bellinzona, Switzerland
[2] Univ Bern, Dept Pediat, Div Human Genet, Bern, Switzerland
[3] Univ Bern, Inst Pathol, Bern, Switzerland
[4] Univ Basel Hosp, Div Clin Pharmacol & Toxicol, Basel, Switzerland
[5] Univ Bern, Inselspital, Dept Neurol, Bern, Switzerland
关键词:
D O I:
10.2310/7010.2006.00047
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
We report on a family with a 12-year-old boy who suffered from a maternally inherited syndrome characterized by a combination of sensorineural hearing loss, myoclonus epilepsy, ataxia, severe psychomotor retardation, short stature, and diabetes mellitus. First, he showed a muscular hypotonia with hearing loss; later, he developed a myoclonus epilepsy, growth failure, and severe psychomotor retardation. At the age of 10 years, he developed diabetes mellitus. After initiation of combined ubiquinone and vitamin C treatment, we observed a progression in psychomotor development. Lactate and pyruvate levels in blood and cerebrospinal fluid were normal. No ragged red fibers or ultrastructural abnormalities were seen in a skeletal muscle biopsy. Biochemical assays of respiratory chain complex activities revealed decreased activity of complexes I and IV. By sequence analysis of mitochondrial DNA encoding transfer ribonucleic acids (RNAs), a homoplasmic T to C substitution at nucleotide position 7512 was found affecting a highly conserved base pair in the tRNA(ser(UCN)) acceptor stem. Asymptomatic family members of the maternal line were heteroplasmic for the mutation in blood samples. Analysis of mitochondrial DNA in patients with hearing loss and myoclonus epilepsy is recommended, even in the absence of laboratory findings. Therapeutically, ubiquinone and antioxidants can be beneficial.
引用
收藏
页码:253 / 255
页数:3
相关论文